203 related articles for article (PubMed ID: 2983428)
1. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
Berman PW; Gregory T; Crase D; Lasky LA
Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.
Berman PW; Vogt PE; Gregory T; Lasky LA; Kern ER
J Infect Dis; 1988 May; 157(5):897-902. PubMed ID: 2834467
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
Hook LM; Cairns TM; Awasthi S; Brooks BD; Ditto NT; Eisenberg RJ; Cohen GH; Friedman HM
PLoS Pathog; 2018 May; 14(5):e1007095. PubMed ID: 29791513
[TBL] [Abstract][Full Text] [Related]
5. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.
Fotouhi F; Soleimanjahi H; Roostaee MH; Dalimi Asl A
Iran Biomed J; 2008 Apr; 12(2):59-66. PubMed ID: 18506211
[TBL] [Abstract][Full Text] [Related]
6. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
Welch MJ; Ridgeway PH; Phillpotts RJ
FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
[TBL] [Abstract][Full Text] [Related]
7. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
[TBL] [Abstract][Full Text] [Related]
9. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use.
Burke RL
Rev Infect Dis; 1991; 13 Suppl 11():S906-11. PubMed ID: 1664126
[TBL] [Abstract][Full Text] [Related]
10. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
[TBL] [Abstract][Full Text] [Related]
12. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
Quenelle DC; Collins DJ; Marciani DJ; Kern ER
Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
Boukhvalova M; McKay J; Mbaye A; Sanford-Crane H; Blanco JC; Huber A; Herold BC
J Virol; 2015 Oct; 89(19):9825-40. PubMed ID: 26178984
[TBL] [Abstract][Full Text] [Related]
14. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
[TBL] [Abstract][Full Text] [Related]
15. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
Simms JR; Heath AW; Jennings R
J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
[TBL] [Abstract][Full Text] [Related]
16. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
Weinberg A; Merigan TC
J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection.
Erturk M; Phillpotts RJ; Welch MJ; Jennings R
Vaccine; 1991 Oct; 9(10):728-34. PubMed ID: 1661978
[TBL] [Abstract][Full Text] [Related]
18. Preinfection prophylaxis with herpes simplex virus glycoprotein immunogens: factors influencing efficacy.
Stanberry LR; Myers MG; Stephanopoulos DE; Burke RL
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3177-85. PubMed ID: 2558156
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
20. Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs.
Quenelle DC; Collins DJ; Rice TL; Prichard MN; Marciani DJ; Kern ER
Antiviral Res; 2008 Nov; 80(2):223-4. PubMed ID: 18573279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]